← Back to Clinical Trials
Recruiting NCT06573359

NCT06573359 Turkish Validity and Reliability of the Expanded Rehabilitation Complexity Scale

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06573359
Status Recruiting
Phase
Sponsor Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 110 participants
Start Date 2024-08-24
Primary Completion 2024-12-26

Eligibility & Interventions

Sex All sexes
Min Age 2 Months
Max Age 6 Months
Study Type OBSERVATIONAL
Interventions
questionnaire

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 110 participants in total. It began in 2024-08-24 with a primary completion date of 2024-12-26.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The RCS is a tool that can assess the need for complex rehabilitation and objectively indicate that a patient may have difficulty functioning well at home or in the community if their medical needs are still high. Among rehabilitation patients, there are still patients with complex needs, even though they have maximized rehabilitation potential. Moreover, RCS can also be useful in highlighting cases of patients becoming seriously ill during the rehabilitation process due to an acute illness such as sepsis, which significantly limits treatment time. This information can be emphasized using RCS data when requesting extended or increased rehabilitation support.

Eligibility Criteria

Inclusion Criteria: Clinical diagnoses of stroke - Exclusion Criteria: unstable cardiac and neurovascular disease \-

Contact & Investigator

Central Contact

sedef ersoy, MD

✉ sedef_ersoy@yahoo.com

📞 +905339532025

Principal Investigator

sedef ersoy

PRINCIPAL INVESTIGATOR

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Frequently Asked Questions

Who can join the NCT06573359 clinical trial?

This trial is open to participants of all sexes, aged 2 Months or older, up to 6 Months, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06573359 currently recruiting?

Yes, NCT06573359 is actively recruiting participants. Contact the research team at sedef_ersoy@yahoo.com for enrollment information.

Where is the NCT06573359 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06573359 clinical trial?

NCT06573359 is sponsored by Istanbul Physical Medicine Rehabilitation Training and Research Hospital. The principal investigator is sedef ersoy at Istanbul Physical Medicine Rehabilitation Training and Research Hospital. The trial plans to enroll 110 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology